4.7 Article

The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer statistics, 2013

Rebecca Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2013)

Review Oncology

Colorectal cancer and RASSF familyuA special emphasis on RASSF1A

Maria Sofia Fernandes et al.

INTERNATIONAL JOURNAL OF CANCER (2013)

Article Multidisciplinary Sciences

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Michael S. Lawrence et al.

NATURE (2013)

Article Genetics & Heredity

Dclk1 distinguishes between tumor and normal stem cells in the intestine

Yuki Nakanishi et al.

NATURE GENETICS (2013)

Letter Oncology

Vimentin in Upper Gastrointestinal Pathologies-Letter

Guro E. Lind et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)

Article Oncology

Aberrant Vimentin Methylation Is Characteristic of Upper Gastrointestinal Pathologies

Helen Moinova et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)

Article Biochemistry & Molecular Biology

Novel target genes and a valid biomarker panel identified for cholangiocarcinoma

Kim Andresen et al.

EPIGENETICS (2012)

Article Gastroenterology & Hepatology

ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis

Trude H. Agesen et al.

Article Oncology

CpG-island methylation study of liver fluke-related cholangiocarcinoma

R. Sriraksa et al.

BRITISH JOURNAL OF CANCER (2011)

Review Cell Biology

CpG islands and the regulation of transcription

Aimee M. Deaton et al.

GENES & DEVELOPMENT (2011)

Article Oncology

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Jacques Ferlay et al.

INTERNATIONAL JOURNAL OF CANCER (2010)

Article Oncology

Analysis of Fecal DNA Methylation to Detect Gastrointestinal Neoplasia

Takeshi Nagasaka et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)

Review Gastroenterology & Hepatology

Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment

Boris Blechacz et al.

HEPATOLOGY (2008)

Editorial Material Biotechnology & Applied Microbiology

Aberrant epigenetic patterns in the etiology of gastrointestinal cancers

Pawel Karpinski et al.

JOURNAL OF APPLIED GENETICS (2008)

Article Medicine, Research & Experimental

Hypermethylated MAL gene -: a silent marker of early colon tumorigenesis

Guro E. Lind et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2008)

Review Pharmacology & Pharmacy

DNA methylation and cancer pathways in gastrointestinal tumors

Hiromu Suzuki et al.

PHARMACOGENOMICS (2008)

Article Genetics & Heredity

Comparing the DNA hypermethylome with gene mutations in human colorectal cancer

Kornel E. Schuebel et al.

PLOS GENETICS (2007)

Review Biochemistry & Molecular Biology

The epigenomics of cancer

Peter A. Jones et al.

Review Oncology

Specificity, selection and significance of gene amplifications in cancer

Samuel Myllykangas et al.

SEMINARS IN CANCER BIOLOGY (2007)

Article Biochemistry & Molecular Biology

DNA copy number amplification profiling of human neoplasms

S. Myllykangas et al.

ONCOGENE (2006)

Article Gastroenterology & Hepatology

Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas

Matthias P. A. Ebert et al.

GASTROENTEROLOGY (2006)

Article Biochemistry & Molecular Biology

Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers

H Taniguchi et al.

ONCOGENE (2005)

Article Biochemistry & Molecular Biology

Analysis of repetitive element DNA methylation by MethyLight

DJ Weisenberger et al.

NUCLEIC ACIDS RESEARCH (2005)

Article Oncology

The Wnt antagonist sFRP1 in colorectal tumorigenesis

GM Caldwell et al.

CANCER RESEARCH (2004)